SCHEMBL6167647

SCHEMBL6167647

O=C1Nc2ccccc2C(c2ccc(Cl)cc2)N1C1CCNCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.38
HTR3A P46098 1/20 0.37
ATM Q13315 1/20 0.37
ABCB1 P08183 1/20 0.36
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
TP53 P04637 2/20 0.36
MDM2 Q00987 2/20 0.36
PRCP P42785 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPK1 P28482 1/20 0.36
TNKS2 Q9H2K2 1/20 0.36
SLC6A3 Q01959 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 1/20 0.35
DRD2 P14416 1/20 0.35
DRD1 P21728 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HTR7 P34969 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5103372 0.91 SLC18A3 (0.40) SLC6A2ATMMEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL8571208 0.90 KDM1A (0.40) SLC6A2ATMMEN1KMT2AALDH1A1
SCHEMBL8568450 0.83 KDM1A (0.38) SLC6A2ATMMEN1KMT2AALDH1A1
SCHEMBL6168165 0.81 CHRM3 (0.49) MEN1KMT2AALDH1A1DRD2
SCHEMBL8569508 0.79 MEN1 (0.53) MEN1KMT2AALDH1A1DRD2
SCHEMBL6168112 0.78 HTR2C (0.50) MEN1KMT2AALDH1A1NPSR1HTR2C
SCHEMBL17803169 0.77 HTR2C (0.41) TP53ALDH1A1MAPK1LMNAHTR2A
SCHEMBL8562015 0.77 TNKS (0.36) ATMMEN1KMT2ATP53TNKS2
SCHEMBL27372547 0.76 ATM (0.57) ATMMEN1KMT2ATP53TNKS2
SCHEMBL8564042 0.75 CHRM2 (0.43) ATMMEN1KMT2APRCPALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1122253-B1 QUINAZOLINONE DERIVATIVES SUMITOMO PHARMA (JP) 2005-08-17 EP disclosed
US-6645971-B1 Pollakiuria and urinary incontinence treatment; muscarinic receptor antagonists; anticholinergic, anticonvulsants, antiulcer, and antiasthmatics; Parkinson*s disease SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) 2003-11-11 US disclosed
EP-1122253-A1 QUINAZOLINONE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2001-08-08 EP disclosed